Product correctly added to cart.

discount label
Levetiracetam-d6
View 3D

Biosynth logo

Levetiracetam-d6

CAS: 1133229-30-7

Ref. 3D-IVB22930

5mg
2,319.00 €
10mg
3,478.00 €
Estimated delivery in United States, on Thursday 9 Jan 2025

Product Information

Name:
Levetiracetam-d6
Controlled Product
Description:

Levetiracetam-d6 is a metabolite of levetiracetam, which is an antiepileptic drug. Levetiracetam-d6 is used as a marker for the determination of plasma concentrations and bioequivalence of levetiracetam. It is also used to study the pharmacokinetics of levetiracetam in healthy Chinese subjects. The plasma concentration-time profile and terminal half-life of levetiracetam and its major metabolite, levetiracetam-d6, were determined from serial blood samples taken from healthy Chinese volunteers following a single oral dose of 1000 mg (2000 mg) levetiracetam. The pharmacokinetic parameters were calculated using noncompartmental analysis with WinNonlin software (Pharsight Corporation). The mean ± SD Cmax and Tmax values for the two substances were 1220 ± 607 ng/mL and 0.5 ± 1 hour, respectively, for

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
176.25 g/mol
Formula:
C8H14N2O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-IVB22930 Levetiracetam-d6

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".